Review



axitinib  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 95
      Buy from Supplier

    Structured Review

    MedChemExpress axitinib
    Axitinib, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 46 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/axitinib/pm41896541-67-3-7?v=MedChemExpress
    Average 95 stars, based on 46 article reviews
    axitinib - by Bioz Stars, 2026-07
    95/100 stars

    Images



    Similar Products

    axitinib  (MedChemExpress)
    95
    MedChemExpress axitinib
    Axitinib, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/axitinib/pm41896541-67-3-7?v=MedChemExpress
    Average 95 stars, based on 1 article reviews
    axitinib - by Bioz Stars, 2026-07
    95/100 stars
    		  Buy from Supplier
    axitinib  (Selleck Chemicals)
    95
    Selleck Chemicals axitinib
    Axitinib, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/axitinib/pm41916996-438-95-96?v=Selleck+Chemicals
    Average 95 stars, based on 1 article reviews
    axitinib - by Bioz Stars, 2026-07
    95/100 stars
    		  Buy from Supplier
    axitinib  (Pfizer Inc)
    86
    Pfizer Inc axitinib
    Axitinib, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/axitinib/us12551564-1110-10-12?v=Pfizer+Inc
    Average 86 stars, based on 1 article reviews
    axitinib - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    vegf inhibitor  (MedChemExpress)
    95
    MedChemExpress vegf inhibitor
    Assessment of the tube formation capability, CD31 and <t>VEGF</t> gene expressions for HUVECs treated without (control) and with cell culture supernatant collected <t>from</t> <t>H-EMSCs</t> seeded on PCL-HA (PCL-HA/H-E) or H-EMSCs and mø co-seeded on PCL-HA (PCL-HA/H-E/mø). A Tube formation assay of HUVECs in the control, PCL-HA/H-E and PCL-HA/H-E/mø groups. Scale bar = 200 μm. B Quantification of the total length of the tubes formed. C Quantification of the total number of meshes formed. D Quantification of the number of nodes formed. E CD31 gene expression of the HUVECs. F VEGF gene expression of the HUVECs. *** p < 0.001. ## p < 0.01, ### p < 0.001 vs. Control
    Vegf Inhibitor, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/axitinib/pmc12988638-80-73-77?v=MedChemExpress
    Average 95 stars, based on 1 article reviews
    vegf inhibitor - by Bioz Stars, 2026-07
    95/100 stars
    		  Buy from Supplier

    Image Search Results


    Assessment of the tube formation capability, CD31 and VEGF gene expressions for HUVECs treated without (control) and with cell culture supernatant collected from H-EMSCs seeded on PCL-HA (PCL-HA/H-E) or H-EMSCs and mø co-seeded on PCL-HA (PCL-HA/H-E/mø). A Tube formation assay of HUVECs in the control, PCL-HA/H-E and PCL-HA/H-E/mø groups. Scale bar = 200 μm. B Quantification of the total length of the tubes formed. C Quantification of the total number of meshes formed. D Quantification of the number of nodes formed. E CD31 gene expression of the HUVECs. F VEGF gene expression of the HUVECs. *** p < 0.001. ## p < 0.01, ### p < 0.001 vs. Control

    Journal: Stem Cell Research & Therapy

    Article Title: Co-delivery of endometrial mesenchymal stem cells and macrophages by an electrospun patch promotes angiogenesis during endometrial injury repair via VEGF related signalling

    doi: 10.1186/s13287-026-04929-2

    Figure Lengend Snippet: Assessment of the tube formation capability, CD31 and VEGF gene expressions for HUVECs treated without (control) and with cell culture supernatant collected from H-EMSCs seeded on PCL-HA (PCL-HA/H-E) or H-EMSCs and mø co-seeded on PCL-HA (PCL-HA/H-E/mø). A Tube formation assay of HUVECs in the control, PCL-HA/H-E and PCL-HA/H-E/mø groups. Scale bar = 200 μm. B Quantification of the total length of the tubes formed. C Quantification of the total number of meshes formed. D Quantification of the number of nodes formed. E CD31 gene expression of the HUVECs. F VEGF gene expression of the HUVECs. *** p < 0.001. ## p < 0.01, ### p < 0.001 vs. Control

    Article Snippet: For the VEGF inhibition experiments, 18 female SD rats in estrus were divided into the following three groups, with 6 rats in each group: PCL-HA/H-E group: PCL-HA electrospun carrier (1 × 10 6 H-EMSCs) was transplanted; PCL-HA/H-E/mø group: PCL-HA electrospun carrier (1 × 10 6 H-EMSCs + 0.25 × 10 6 mø) was transplanted; PCL-HA/H-E/mø/VEGF inhibitor group: PCL-HA electrospun carrier (1 × 10 6 H-EMSCs and 0.25 × 10 6 mø) was implanted, VEGF inhibitor (Axitinib (HY-10065, MCE), 100 mg/kg) was injected into the rat uterine cavity.

    Techniques: Control, Cell Culture, Tube Formation Assay, Gene Expression

    Assessment of the tube formation capability, CD31 and VEGF gene expressions of HUVECs treated with cell culture supernatant collected from H-EMSCs seeded on PCL-HA (PCL-HA/H-E) or H-EMSCs and mø co-seeded on PCL-HA (PCL-HA/H-E/mø) or H-EMSCs and mø co-seeded on PCL-HA and VEGF inhibitor (PCL-HA/H-E/mø/VEGF inhibitor). A Tube formation assay of HUVECs in the PCL-HA/H-E, PCL-HA/H-E/mø and PCL-HA/H-E/mø/VEGF inhibitor groups. Scale bar = 200 μm. B Quantification of the total length of the tubes formed. C Quantification of the total number of meshes formed. D Quantification of the number of nodes formed. E CD31 gene expression of the HUVECs. F VEGF gene expression of the HUVECs. *** p < 0.001. # p < 0.05, ### p < 0.001 vs. PCL-HA/H-E group

    Journal: Stem Cell Research & Therapy

    Article Title: Co-delivery of endometrial mesenchymal stem cells and macrophages by an electrospun patch promotes angiogenesis during endometrial injury repair via VEGF related signalling

    doi: 10.1186/s13287-026-04929-2

    Figure Lengend Snippet: Assessment of the tube formation capability, CD31 and VEGF gene expressions of HUVECs treated with cell culture supernatant collected from H-EMSCs seeded on PCL-HA (PCL-HA/H-E) or H-EMSCs and mø co-seeded on PCL-HA (PCL-HA/H-E/mø) or H-EMSCs and mø co-seeded on PCL-HA and VEGF inhibitor (PCL-HA/H-E/mø/VEGF inhibitor). A Tube formation assay of HUVECs in the PCL-HA/H-E, PCL-HA/H-E/mø and PCL-HA/H-E/mø/VEGF inhibitor groups. Scale bar = 200 μm. B Quantification of the total length of the tubes formed. C Quantification of the total number of meshes formed. D Quantification of the number of nodes formed. E CD31 gene expression of the HUVECs. F VEGF gene expression of the HUVECs. *** p < 0.001. # p < 0.05, ### p < 0.001 vs. PCL-HA/H-E group

    Article Snippet: For the VEGF inhibition experiments, 18 female SD rats in estrus were divided into the following three groups, with 6 rats in each group: PCL-HA/H-E group: PCL-HA electrospun carrier (1 × 10 6 H-EMSCs) was transplanted; PCL-HA/H-E/mø group: PCL-HA electrospun carrier (1 × 10 6 H-EMSCs + 0.25 × 10 6 mø) was transplanted; PCL-HA/H-E/mø/VEGF inhibitor group: PCL-HA electrospun carrier (1 × 10 6 H-EMSCs and 0.25 × 10 6 mø) was implanted, VEGF inhibitor (Axitinib (HY-10065, MCE), 100 mg/kg) was injected into the rat uterine cavity.

    Techniques: Cell Culture, Tube Formation Assay, Gene Expression

    VEGF, CD31 gene and protein expression of rat endometrial tissues of the PCL-HA/H-E, PCL-HA/H-E/mø and PCL-HA/H-E/mø/VEGF inhibitor groups at day 7. A VEGF gene expression. B Quantification of VEGF protein concentration (pg/ml). C Representative images of VEGF immunostaining. Cell nuclei stained in blue while VEGF stained in red. Scale bar = 100 μm. D Quantification of VEGF staining area (%). E CD31 gene expression. F Representative images of CD31 immunostaining. Cell nuclei stained in blue while CD31 stained in red. Scale bar = 100 μm. G Quantification of CD31 staining area (%). *** p < 0.001. ## p < 0.01, ### p < 0.001 vs. PCL-HA/H-E group

    Journal: Stem Cell Research & Therapy

    Article Title: Co-delivery of endometrial mesenchymal stem cells and macrophages by an electrospun patch promotes angiogenesis during endometrial injury repair via VEGF related signalling

    doi: 10.1186/s13287-026-04929-2

    Figure Lengend Snippet: VEGF, CD31 gene and protein expression of rat endometrial tissues of the PCL-HA/H-E, PCL-HA/H-E/mø and PCL-HA/H-E/mø/VEGF inhibitor groups at day 7. A VEGF gene expression. B Quantification of VEGF protein concentration (pg/ml). C Representative images of VEGF immunostaining. Cell nuclei stained in blue while VEGF stained in red. Scale bar = 100 μm. D Quantification of VEGF staining area (%). E CD31 gene expression. F Representative images of CD31 immunostaining. Cell nuclei stained in blue while CD31 stained in red. Scale bar = 100 μm. G Quantification of CD31 staining area (%). *** p < 0.001. ## p < 0.01, ### p < 0.001 vs. PCL-HA/H-E group

    Article Snippet: For the VEGF inhibition experiments, 18 female SD rats in estrus were divided into the following three groups, with 6 rats in each group: PCL-HA/H-E group: PCL-HA electrospun carrier (1 × 10 6 H-EMSCs) was transplanted; PCL-HA/H-E/mø group: PCL-HA electrospun carrier (1 × 10 6 H-EMSCs + 0.25 × 10 6 mø) was transplanted; PCL-HA/H-E/mø/VEGF inhibitor group: PCL-HA electrospun carrier (1 × 10 6 H-EMSCs and 0.25 × 10 6 mø) was implanted, VEGF inhibitor (Axitinib (HY-10065, MCE), 100 mg/kg) was injected into the rat uterine cavity.

    Techniques: Expressing, Gene Expression, Protein Concentration, Immunostaining, Staining

    H&E staining of rat endometrial tissues of the following groups: PCL-HA carrier with H-EMSCs mono-delivery (PCL-HA/H-E), PCL-HA carrier with H-EMSCs and mø co-delivery (PCL-HA/H-E/mø) and PCL-HA/H-E/mø with VEGF inhibitor (PCL-HA/H-E/mø/VEGF inhibitor), at day 7. A Representative H&E images of the rat endometrial tissues of the different treatment groups at day 7. Scale bar = 560 μm. Enlarged images are shown at the bottom and scale bar = 220 μm. B Quantification of the endometrium thickness. C Quantification of the number of endometrial glands. *** p < 0.001, ## p < 0.01, ### p < 0.001 vs. PCL-HA/H-E group

    Journal: Stem Cell Research & Therapy

    Article Title: Co-delivery of endometrial mesenchymal stem cells and macrophages by an electrospun patch promotes angiogenesis during endometrial injury repair via VEGF related signalling

    doi: 10.1186/s13287-026-04929-2

    Figure Lengend Snippet: H&E staining of rat endometrial tissues of the following groups: PCL-HA carrier with H-EMSCs mono-delivery (PCL-HA/H-E), PCL-HA carrier with H-EMSCs and mø co-delivery (PCL-HA/H-E/mø) and PCL-HA/H-E/mø with VEGF inhibitor (PCL-HA/H-E/mø/VEGF inhibitor), at day 7. A Representative H&E images of the rat endometrial tissues of the different treatment groups at day 7. Scale bar = 560 μm. Enlarged images are shown at the bottom and scale bar = 220 μm. B Quantification of the endometrium thickness. C Quantification of the number of endometrial glands. *** p < 0.001, ## p < 0.01, ### p < 0.001 vs. PCL-HA/H-E group

    Article Snippet: For the VEGF inhibition experiments, 18 female SD rats in estrus were divided into the following three groups, with 6 rats in each group: PCL-HA/H-E group: PCL-HA electrospun carrier (1 × 10 6 H-EMSCs) was transplanted; PCL-HA/H-E/mø group: PCL-HA electrospun carrier (1 × 10 6 H-EMSCs + 0.25 × 10 6 mø) was transplanted; PCL-HA/H-E/mø/VEGF inhibitor group: PCL-HA electrospun carrier (1 × 10 6 H-EMSCs and 0.25 × 10 6 mø) was implanted, VEGF inhibitor (Axitinib (HY-10065, MCE), 100 mg/kg) was injected into the rat uterine cavity.

    Techniques: Staining